An open‐label non‐inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma.

MLA

Ray, Animesh, et al. “An Open‐label Non‐inferiority Randomised Control Trial Comparing Nebulised Amphotericin B with Oral Itraconazole in Patients with Pulmonary Aspergilloma.” Mycoses, vol. 64, no. 9, Sept. 2021, pp. 1038–44. EBSCOhost, https://doi.org/10.1111/myc.13329.

APA

Ray, A., Manikanta, J., Singh, K., Gabra, P., Vyas, S., Singh, G., Xess, I., Sethi, P., Meena, V. P., Soneja, M., Sinha, S., Wig, N., & Kabra, S. (2021). An open‐label non‐inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma. Mycoses, 64(9), 1038–1044. https://doi.org/10.1111/myc.13329

Chicago

Ray, Animesh, Jagdeesh Manikanta, Komal Singh, Pavan Gabra, Surabhi Vyas, Gagandeep Singh, Immaculata Xess, et al. 2021. “An Open‐label Non‐inferiority Randomised Control Trial Comparing Nebulised Amphotericin B with Oral Itraconazole in Patients with Pulmonary Aspergilloma.” Mycoses 64 (9): 1038–44. doi:10.1111/myc.13329.